Aditxt (ADTX) Gross Margin (2022 - 2026)

Aditxt (ADTX) recorded quarterly Gross Margin of 23.59% in Q1 2026, up 423.38% quarter-over-quarter from 7.29% in Q4 2025, and down 431.0% on a YoY basis from 7.13% in Q1 2025.

Aditxt (ADTX) Gross Margin (2022 - 2026) Analysis & Trends

Aditxt's Gross Margin history runs 5 years deep, the most recent figure standing at 23.59% for Q1 2026.

  • In Q1 2026, Gross Margin fell 431.0% year-over-year to 23.59%; the TTM figure through Mar 2026 stood at 19.89% (up 93649.0% YoY), while the FY2025 annual figure was 8.39%, up 37670.0% from the prior year.
  • Gross Margin was 23.59% for Q1 2026 at Aditxt, up from 7.29% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 47.75% in Q2 2024 to a low of 6721.36% in Q3 2024.
  • Historically, Gross Margin has averaged 522.61% across 5 years, with a median of 14.11% in 2023.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin slumped 673547 bps in 2024, then soared 672350 bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 8.31% in 2022, then plunged by 3127 bps to 251.63% in 2023, then plunged by 749 bps to 2136.38% in 2024, then soared by 100 bps to 7.29% in 2025, then jumped by 423 bps to 23.59% in 2026.
  • The last three Gross Margin figures came in at 23.59% (Q1 2026), 7.29% (Q4 2025), and 2.14% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Aditxt 2,485.68 -2.16 Mn 2,868.00 23.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 23.59%
Dec 31, 2025 -7.29%
Sep 30, 2025 2.14%
Jun 30, 2025 -0.10%
Mar 31, 2025 27.90%
Dec 31, 2024 -2,136.38%
Sep 30, 2024 -6,721.36%
Jun 30, 2024 47.75%
Mar 31, 2024 17.42%
Dec 31, 2023 -251.63%
Sep 30, 2023 14.11%
Jun 30, 2023 15.95%
Mar 31, 2023 18.36%
Dec 31, 2022 8.31%
Sep 30, 2022 27.68%
Jun 30, 2022 18.56%
Mar 31, 2022 10.56%